Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department

European Journal of Endocrinology

Volumn 154, Issue 6, 2006, Pages 835-841

  Vantyghem, Marie Christine ^a   Fajardy, Isabelle ^a   Dhondt, Florence ^a   Girardot, Caroline ^a   D'Herbomez, Michèle ^a   Danze, Pierre Marie ^a   Rousseaux, Jean ^a   Wemeau, Jean Louis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; FERRITIN; HFE PROTEIN; IRON; LIVER ENZYME; TRANSFERRIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINOLOGY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL DEPARTMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; DIABETES MELLITUS; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; TRANSFERRIN;

EID: 33745712799     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02152     Document Type: Article

References (25)

1. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. New England Journal of Medicine 2004 350 2383-2397.
2. Beutler E, Felitti VJ, Koziol JA, Ho NJ & Gelbart T. Penetrance of 845G - A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002 359 211-218.
3. McCune CA, Al-Jader LN, May A, Hayes SL, Jackson HA & Worwood M. Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Human Genetics 2002 111 538-543.
4. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L & Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. New England Journal of Medicine 1999 341 718-724.
5. Jehn M, Clark JM & Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care 2004 27 2422-2428.
6. Woolf B. On estimating the relation between blood group and disease. American Journal of Human Genetics 1955 19 251-253.
7. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. American Journal of Human Genetics 1956 20 309-311.
8. Adams PC, Reboussin DM, Barton JC, Mc Laren CE, Eecfeldt JH, Mc Laren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E & Sholinsky P for the Hemochromatosis and Iron overload (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in racially diverse population. New England Journal of Medicine 2005 352 1769-1778.
9. Njajou OT, Alizadeh BZ, Vaessen N, Vergeer J, Houwing-Duistermaat J, Hofman A, Pols HA & Van Duijn CM. The role of hemochromatosis C282Y and H63D gene mutations in type 2 diabetes: findings from the Rotterdam Study and meta-analysis. Diabetes Care 2002 25 2112-2113.
10. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V & Deugnier Y. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999 117 1155-1163.
11. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA & Salonen JT. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1013 eastern Finnish men. Diabetes Care 1997 20 426-428.
12. Dubois-Laforgue D, Larger E & Timsit J. Is diabetes mellitus a sufficient condition to suspect hemochromatosis? Diabetes and Metabolism 2000 26 318-321.
13. Van Lerberghe S, Hermans MP, Dahan K & Buysschaert M. Clinical expression and insulin sensitivity in type 2 diabetic patients with heterozygous mutations for haemochromatosis. Diabetes and Metabolism 2002 28 33-38.
14. Salonen JT, Tuomainen TP & Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. British Medical Journal 2000 320 1706-1707.
15. Moczulski DK, Grzeszczak W & Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001 24 1187-1191.
16. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N & Hu FB. Body, iron stores in relation to risk of type 2 diabetes in apparently healthy women. Journal of the American Medical Association 2004 291 711-717.
17. Halsall DJ, McFarlane I, Luan J, Cox TM & Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case-control study. Human Molecular Genetics 2003 12 1361-1365.
18. Sampson MJ, Williams T, Heyburn PJ, Greenwood RH, Temple RC, Wimperis JZ, Jennings BA & Willis GA. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. Journal of Laboratory and Clinical Medicine 2000 135 170-173.
19. Fernandez-Real JM, Lopez-Bermejo A & Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002 51 2348-2354.
20. Hellerbrand C, Poppl A, Hartmann A, Scholmerich J & Lock G, HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. Clinical Gastroenterology and Hepatology 2003 1 279-284.
21. Mainous AG, 3rd, Gill JM & Carek PJ. Elevated serum transferrin saturation and mortality. Annals of Family Medicine 2004 2 133-138.
22. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ & Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. New England Journal of Medicine 1985 313 1256-1262.
23. Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA & Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with ApoE. American Journal of Medical Genetics 2003 119B 48-53.
24. Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, Butzkueven H, Chapman C, Johnson L, Marriott M, Mraz G, Tait B, Wilkinson C, Taylor B, Speed TP, Foote SJ & Kilpatrick TJ. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Human Genetics 2004 114 573-580.
25. Guillygomarc'h A, Mendler MH, Moirand R, Laine F, Quentin V, David V, Brissot P & Deugnier Y. Venesection therapy of insulin resistance-associated hepatic iron overload. Journal of Hepatology 2001 35 344-349.